Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03242889. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00256880. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03311828. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PROFAST Intervention in Precursor Multiple Myeloma
ClinicalTrials.gov study NCT05565638. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of Real-Life Current Standards of Care in Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05160584. IPD Sharing: YES. Countries: 11. Publications: 3.
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01863550. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)
ClinicalTrials.gov study NCT00633542. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT01376401. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase II Study of BI-505 in Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT01838369. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd)
ClinicalTrials.gov study NCT01857115. IPD Sharing: Not stated. Countries: 1. Publications: 2.
HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT02569320. IPD Sharing: NO. Countries: 1. Publications: 1.
Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
ClinicalTrials.gov study NCT04483739. IPD Sharing: UNDECIDED. Countries: 8. Publications: 0.
Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma
ClinicalTrials.gov study NCT00003007. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fenofibrate Role in the Prophylaxis From Peripheral Neuropathy Induced by Bortezomib, Lenalidomide and Dexamethasone (VRd) Protocol in the Treatment of Patients With Multiple Myeloma (MM)
ClinicalTrials.gov study NCT07025005. IPD Sharing: NO. Countries: 1. Publications: 6.
Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma
ClinicalTrials.gov study NCT00201695. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)
ClinicalTrials.gov study NCT04557150. IPD Sharing: YES. Countries: 9. Publications: 1.
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05572515. IPD Sharing: YES. Countries: 24. Publications: 0.
Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT00305812. IPD Sharing: NO. Countries: 1. Publications: 2.
Teclistamab-Daratumumab and Talquestamab-Daratumumab in Newly Diagnosed High-risk Multiple Myeloma
ClinicalTrials.gov study NCT05849610. IPD Sharing: Not stated. Countries: 1. Publications: 45.
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma
ClinicalTrials.gov study NCT03119883. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.